Rivoceranib + Paclitaxel
NCT05905887
Asan Medical Center · Phase 2 · Recruiting · Enrollment 48
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
Rivoceranib + Paclitaxel
Asan Medical Center · Phase 2 · Recruiting · Enrollment 48
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.